Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here’s Why Global Blood, Deutsche Bank, PayPal, and Two Other Stocks Are Trending Today

Amid another spate of earnings releases all three main stock indexes are trading lower today. The Dow Jones is down by 0.21%, the S&P 500 is 0.30% in the red, and the NASDAQ index is close has lost around 0.35%.

In this article, we examine why five stocks, Alibaba Group Holding Ltd (NYSE:BABA), Paypal Holdings Inc (NASDAQ:PYPL), Global Blood Therapeutics Inc (NASDAQ:GBT), Chesapeake Energy Corporation (NYSE:CHK), and Deutsche Bank AG (USA) (NYSE:DB) are on investors’ radars on Tuesday. In addition, we are going to assess the hedge fund sentiment towards the companies in question.

Through extensive research, we determined that imitating some of the picks of hedge funds and other institutional investors can help generate market-beating returns over the long run. The key is to focus on the small-cap picks of these investors, since they are usually less followed by the broader market and are less price-efficient. Our backtests that covered the period between 1999 and 2012, showed that following the 15 most popular small-caps among hedge funds can help a retail investor beat the market by an average of 95 basis points per month (see the details here).

paypal, buy, rose, business, app, editorial, technology, touch, computer, phablet, mobile, woman, electronic, smartphone, payment, purchase, background, device, online,

Denys Prykhodov /

Traders are watching Alibaba Group Holding Ltd (NYSE:BABA) after Goldman Sachs analyst Piyush Mubayi hiked his price target on the e-commerce giant’s stock to $130 from $120 per share and maintained the stock in the Goldman’s ‘Conviction Buy’ list. Mubayi likes Alibaba’s organic growth outlook and thinks the company’s margin outlook for its core business is solid. Alibaba shares are up 28% year-to-date. Of the 749 funds we track, 69 funds owned $5.52 billion worth of Alibaba Group Holding Ltd (NYSE:BABA)’s stock, which accounted for 2.80% of the float on June 30, versus 67 funds and $5.14 billion, respectively, on March 31.

Follow Alibaba Group Holding Limited (NYSE:BABA)
Trade (NYSE:BABA) Now!

Paypal Holdings Inc (NASDAQ:PYPL) is in the spotlight after the payments giant announced that it has extended its relationship with Facebook Inc (NASDAQ:FB). In particular, PayPal will be a payment option across more of Facebook’s commerce interfaces, including Messenger commerce. Given that Facebook has over 1.0 billion active users across its platforms, the increased integration with the giant is certainly good news for PayPal in the near term. A total of 84 funds from our database owned shares of Paypal Holdings Inc (NASDAQ:PYPL) at the end of the second quarter, down by three funds from the previous quarter.

Follow Paypal Holdings Inc. (NASDAQ:PYPL)
Trade (NASDAQ:PYPL) Now!

On the next page, we find out why the spotlight is shining on Global Blood, Chesapeake Energy Corporation, and Deutsche Bank AG (USA).

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.